Increasing bioavailability in supplements can improve health and quality of life outcomes for patients, be a better use of resources from an ecological perspective and yield better results from a business perspective.

Immediate engagement needed now to make hemp a valid commodity crop.

Supply chain scrutiny is made even more difficult when ingredient buyers are looking to diversify, a prospect that’s more top of mind today with the onset of the global pandemic. But efforts are being devoted to bring a new level of clarity to the...

As FDA continues to evaluate regulatory frameworks for CBD, the states have emerged as the key regulators of the popular ingredient.

How is your natural products brand viewing innovation during this challenging year? Are you cutting back and focusing on core products or going all in on new lines, packaging and more? This survey wants to measure what innovation is happening in...

Wild plant ingredients are core components of many natural supplements, but the nature of their supply chains carries inherent sustainability risks. FairWild certification can help.